8 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19088496 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | HANEY, AMANDA MARIE | 1682 | Non-Final OA | Mar 24, 2025 |
| 19088442 | METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY | WHALEY, PABLO S | 3619 | Final Rejection | Mar 24, 2025 |
| 19087361 | METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY | JOHANNSEN, DIANA B | 1682 | Non-Final OA | Mar 21, 2025 |
| 18076279 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY IN BREAST CANCER SUBTYPES | HOPPE, EMMA RUTH | 1683 | Non-Final OA | Dec 06, 2022 |
| 17678357 | GENE SIGNATURES FOR CANCER PROGNOSIS | HORLICK, KENNETH R | 1681 | Final Rejection | Feb 23, 2022 |
| 17499284 | METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY | WHALEY, PABLO S | 3619 | Final Rejection | Oct 12, 2021 |
| 17353279 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | HANEY, AMANDA MARIE | 1682 | Non-Final OA | Jun 21, 2021 |
| 16664216 | CANCER BIOMARKERS | LIN, JERRY | 1685 | Non-Final OA | Oct 25, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial